Abstract
Purpose. Women who undergo a benign breast biopsy are at elevated risk for the subsequent development of breast cancer (BC). Therefore, appropriate clinical follow-up of a benign breast biopsy is important. The present study examines the extent and correlates of nonadherence with follow-up recommendations after a benign breast biopsy.
Methods. Women (n = 114) who had undergone a benign breast biopsy completed an initial telephone interview within 50 days of their biopsy (mean = 21 days). Additional telephone interviews were completed at 4 and 8 months post-biopsy. Measures of BC risk perception, general and BC-specific distress, BC-related attitudes and beliefs, social support, optimism, and informational coping style were completed. Specific recommendations for clinical follow-up and evidence of actual follow-up were obtained from medical records.
Results. Of 103 women given a specific recommendation for clinical follow-up, 34% were classified as nonadherent with follow-up recommendations. Logistic regression analyses indicated that nonadherent women were characterized by younger age, recommendations for follow-up by clinical breast examination alone, greater confidence in their ability to perform breast self-examination properly, higher perceived personal risk for BC, and greater BC-specific distress.
Conclusion. Despite the importance of appropriate clinical follow-up of a benign breast biopsy, about one-third of women did not adhere to recommended follow-up. Risk factors for nonadherence suggest potential avenues for interventions to enhance participation in appropriate clinical follow-up.
Similar content being viewed by others
References
de Koning HJ, Francheboud J, Boer R, Verbeek AL, Collette HJ, Hendriks JH, van Ineveld BM, de Bruyn AE, van derMaas PJ: Nation-wide breast cancer screening in The Netherlands: support for breast cancer mortality reduction. Int J Cancer 60: 777-780, 1995
Morrison AS, Brisson J, Khalid N: Breast cancer incidence and mortality in the breast cancer demonstration project. J Natl Cancer Inst 80: 1540-1547, 1988
Shapiro S, Venet W, Strax P, Venet L, Roeser R: Ten to 14-year effect of screening on breast cancer mortality. J Natl Cancer Inst 69: 349-355, 1982
Shapiro S, Venet W, Strax P, Venet L, Roeser R: Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. J Natl Cancer Inst Monogr 67: 65-74, 1985
Brenner RJ, Sickles EA: Acceptability of periodic followup as an alternative to biopsy for mammographically detected lesions interpreted as probably benign. Radiology 171: 645-646, 1989
Winchester DP, Lasky HJ, Sylvester J, Maher ML: A television-promoted mammography screening pilot project in the Chicago metropolitan area. CA Cancer J Clin 38: 291-309, 1988
Laya MB, Larson EB, Taplin SH, White E: Effect of estrogen replacement therapy on the sensitivity and specificity of screening mammography. J Natl Cancer Inst 88: 643-649, 1996
Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG: Prognostic significance of benign proliferative breast disease. Cancer 71: 3896-3907, 1993
Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR: A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128: 467-477, 1988
Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312: 146-151, 1985
London SJ, Connolly JL, Schnitt SJ, Colditz GA: A prospective study of benign breast disease and the risk of breast cancer. JAMA 267: 941-944, 1992
McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D: Histologic types of benign breast disease and the risk for breast cancer. Cancer 69: 1408-1414, 1992
Baker F: Behavioral science applied to cancer screening. Curr Opin Oncol 10: 455-460, 1998
Bond JH: Colorectal cancer screening. Curr Opin Oncol 10: 461-466, 1998
Rimer BK: Mammography use in the US: trends and the impact of intervention. Ann Behav Med 16: 317-326, 1994
Eddy DM, Hasselblad V, McGivney W, Hendee W: The value of mammography screening in women under age 50 years. JAMA 259: 1512-1519, 1988
Lane DS: Compliance with referals from a cancer-screening project. J Fam Pract 17: 811-817, 1983
Lerman C, Hanjani P, Caputo C, Miller S, Delmoor E, Nolte S, Engstrom P: Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol 10: 300-303, 1992
McCarthy BD, Ulcikas YM, Boohaker EA, Ward RE, Rebner M, Johnson CC: Inadequate follow-up of abnormal mammograms. Am J Prev Med 12: 282-288, 1996
McCarthy BD, Yood MU, Janz NK, Boohaker EA, Ward RE, Johnson CC: Evaluation of factors potentially associated with inadequate follow-up of mamographic abnormalities. Cancer 77: 2070-2076, 1996
Benedict S, Williams R, Baron P: Recalled anxiety: from discovery to diagnosis of a benign breast mass. Oncol Nurs Forum 21: 1723-1727, 1994
Michielutte R, Diseker RA, Young LD, May WJ: Noncompliance in screening follow-up among family planning clinic patients with cervical dysplasia. Prev Med 14: 248-258, 1985
Hughes JE, Royle GT, Buchanan R, Taylor L: Depression and social stress among patients with benign breast disease. Br J Surg 73: 997-999, 1986
Hughson AVM, Cooper AF, McArdle CS, Smith DC: Psychosocial morbidity in patients awaiting breast biopsy. J Psychosom Res 32: 173-180, 1988
Northouse LL, Jeffs M, Cracchiolo-Caraway A, Lampman L, Dorris G: The emotional distress reported by women & husbands prior to a breast biopsy. Nurs Res 44: 196-201, 1995
Northouse LL, Tocco KM, West P: Coping with a breast biopsy: how healthcare professionals can help women and their husbands. Oncol Nurs Forum 24: 473-480, 1997
Scott D: Anxiety, critical thinking and information processing during and after breast biopsy. Nurs Res 32: 24-28, 1983
Chen CC, David A, Thompson K, Smith C, Lea S, Fahy T: Coping strategies and psychiatric morbidity in women attending breast assessment clinics. J Psychosom Res 40: 265-270, 1996
Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF: Factors associated with repeat adherence to breast cancer screening. Prev Med 19: 279-290, 1990
Haefner DP, Becker MH, Janz NK, Rutt WM: Impact of a negative breast biopsy on subsequent breast self-examination practice. Patient Edu Counsel 14: 137-146, 1989
Janz NK, Becker MH, Haefner DP, Rutt WM, Weissfeld LA: Determinants of breast self-examination after a benign breast biopsy. Am J Prev Med 6: 84-92, 1990
Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being screened annually. J Natl Cancer Inst 81: 1879-1886, 1989
Benichou J: A computer program for estimating individualized probabilities of breast cancer. Comput Biomed Res 26: 373-382, 1993
Steptoe A: An abbreviated version of the Miller behavioral style scale. Br J Clin Psychol 28: 183-184, 1989
Scheier MF, Carver CA: Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol 4: 219-247, 198
Shacham S: A shortened version of the profile of mood states. J Pers Assess 47: 305-306, 1983
Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure 1: 385-401, 1977
Horowitz M, Wilner N, Alvarez W: Impact of event scale: a measure of subjective stress. Psychosom Med 41: 209-218, 1979
Broadhead WE, Gehlbach SH, De Gruy FV, Kaplan BH: The Duke-UNC functional social support questionnaire: measurement of social support in family medicine patients. Med Care 26: 709-723, 1988
Cunningham LLC, Andrykowski MA, Wilson JF, McGrath PC, Sloan DA, Kenady DE: Physical symptoms, distress, and breast cancer risk perceptions in women with benign breast problems. Health Psychol 17: 371-375, 1998
Lerman C, Trock B, Rimer BK, Jepson C, Brady D, Boyce A: Psychological side effects of breast cancer screening. Health Psychol 10: 259-267, 1991
Stark A, Hulka BS, Joens S, Novotny D, Thor AD, Wold LE, Schell MJ, Melton III LJ, Liu ET, Convay K: HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer. J Clin Oncol 18: 267-274, 2000
Alagna SW, Morokoff PJ, Bevett JM, Reddy DM: Performance of breast self-examination by women at high risk for breast cancer. Women Health 12: 29-46, 1987
Diefenbach MA, Miller SM, Daly MB: Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychol 18: 532-536, 1999
Greenwald HP, Becker SW, Nevitt MC: Delay and noncompliance in cancer detection: A behavioral perspective for health planners. Milbank Q 56: 212-230, 1978
Kash KM, Holland JC, Halper MS, Miller DG: Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 84: 24-30, 1992
Macdonald LA, Sackett DL, Haynes RB, Taylor DW: Labelling in hypertension: a review of the behavioural and psychological consequences. J Chronic Dis 37: 933-942, 1984
Leventhal H: Findings and theory in the study of fear communications. In: Berkowitz L (ed) Advances in Experimental Social Psychology. Vol 5, Academic Press, New York, 1970, pp 1208-1224
Leventhal H, Zimmerman R, Guttmann M: Compliance: a self-regulation perspective. In: Gentry DW (ed) Handbook of Behavioral Medicine. Guilford Press, New York, 1984, pp 369-436
American Cancer Society: Cancer Facts and Figures-1998. American Cancer Society, Atlanta, 1998, p 31
NIH Consensus Development Panel: National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. J Natl Cancer Inst 89: 1015-1026, 1997
Kash KM, Holland JC, Osborne MP, Miller DG: Psychological counseling strategies for women at risk of breast cancer. J Natl Cancer Inst Monogr 17: 73-79, 199
Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, Balshem A: Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 87: 286-292, 1995
Lerman C, Schwartz MD, Miller SM, Daly M, Sands C, Rimer BK: A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level & coping style. Health Psychol 15: 75-83, 1996
Lerman C, Ross E, Boyce A, McGovern Gorchov P, Mclaughlin R, Rimer B, Engstrom P: The impact of mailing psychoeducational materials to women with abnormal mammograms. Am J Pub Health 82: 729-730, 1992
Manfredi C, Lacey L, Warnecke R: Results of an intervention to improve compliance with referrals for evaluation of suspected malignancies at neighborhood public health centers. Am J Pub Health 80: 85-87, 1990
Miller SM, Siejak KK, Schroeder CM, Lerman C, Hernandez E, Helm CW: Enhancing adherence following abnormal Pap smears among low income minority women: a preventive telephone counseling strategy. J Natl Cancer Inst 89: 703-708, 1997
Paskett ED, White E, Carber WB, Chu J: Improving followup after an abnormal pap smear: a randomized controlled trial. Prev Med 19: 630-641, 1990
Schwartz MD, Lerman C, Audra in J, Cella D, Rimer B, Stefanek M, Garber J, Lin TH, Vogel V: The impact of a brief problem-solving training intervention for relatives of recently diagnosed breast cancer patients. Ann Behav Med 20: 7-12, 1998
Schwartz MD, Rimer BK, Daly M, Sands C, Lerman C: A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use. Am J Pub Health 89: 924-926, 1999
McBride CM, Scholes D, Grothaus LC, Curry SJ, Ludman E, Albright J: Evaluation of a minimal self-help smoking cessation intervention following cervical cancer screening. Prev Med 29: 133-138, 1999
Nutting PA: Health promotion in primary medical care: problems and potential. Prev Med 15: 537-548, 1986
Schilling A, Conaway MR, Wingate PJ, Atkins JN, Berkowitz IM, Clamon GH, DiFino SM, Vinciguerra V: Recruiting cancer patients to participate in motivating their relatives to quit smoking: a cancer control study of the Cancer and Leukemia Group B (CALGB 9072). Cancer 79: 152-160, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andrykowski, M.A., Carpenter, J.S., Studts, J.L. et al. Adherence to recommendations for clinical follow-up after benign breast biopsy. Breast Cancer Res Treat 69, 165–178 (2001). https://doi.org/10.1023/A:1012272031953
Issue Date:
DOI: https://doi.org/10.1023/A:1012272031953